An Act relative to assessing the feasibility of in-state drug manufacturing
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill directs the General Court to investigate the feasibility of the state of Massachusetts sponsoring the manufacturing or distribution of prescription drugs within the state. The investigation will be conducted by a special commission including members of the General Court. The goal is to assess whether in-state drug production could benefit the Commonwealth, potentially addressing issues like cost and access to medications.
Key provisions
- Establish a special commission to study in-state drug manufacturing.
- The commission will include members of the General Court.
- The commission will assess the feasibility of state-sponsored drug manufacturing or distribution.
- The study will consider potential benefits and challenges.
- The commission’s findings will be reported to the legislature.
Who is affected
- Pharmaceutical industry
- Healthcare providers
- Patients
- Massachusetts residents
- The Commonwealth of Massachusetts
Notable changes
- This bill initiates a study rather than enacting any specific changes to current law.
- It focuses on assessing feasibility, not on establishing a program immediately.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
4 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours